Related Experiment Videos

ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5

H Hsu1, I Solovyev, A Colombero

  • 1Department of Cell Biology, Amgen Inc., Thousand Oaks, California 91320, USA. hhsu@amgen.com

Insights

Researchers identified ATAR, the shortest known tumor necrosis factor receptor (TNFR) superfamily member. ATAR interacts with TRAF proteins, activating NF-kappaB, suggesting distinct signaling roles for TRAF2 and TRAF5.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Tumor necrosis factor receptor (TNFR) superfamily members mediate cellular signaling pathways.
  • These pathways often involve interactions with death domain and TRAF proteins.

Purpose of the Study:

  • To identify and characterize novel members of the TNFR superfamily.
  • To investigate the signaling mechanisms of a newly discovered TNFR member, ATAR.

Main Methods:

  • Sequence analysis to identify novel TNFR family members.
  • Expression analysis in various tissues.
  • Co-immunoprecipitation assays to study protein interactions.
  • Reporter assays to measure NF-kappaB activation.

Main Results:

  • Identification of ATAR, the shortest known TNFR superfamily member.
  • ATAR expression is prominent in immune organs (spleen, thymus, bone marrow) and lung, small intestine.
  • ATAR interacts with TRAF2 and TRAF5 via its C-terminal 20 amino acids.
  • ATAR activates NF-kappaB, with synergistic activation observed when co-expressed with TRAF5.

Conclusions:

  • ATAR represents a novel, compact member of the TNFR superfamily.
  • ATAR signaling involves TRAF protein interactions and NF-kappaB activation.
  • Differential interaction with TRAF5 suggests distinct roles in downstream signaling pathways.

Related Concept Videos